Clearmind Medicine (CMND) Short-term Investments (2021 - 2026)

Clearmind Medicine's Short-term Investments history runs 6 years deep, the most recent figure standing at $2.2 million for Q2 2026.

• In Q2 2026, Short-term Investments rose 1125.77% year-over-year to $2.2 million; the TTM figure through Apr 2026 stood at $2.2 million (up 1125.77% YoY), while the FY2025 annual figure was $1.7 million, up 474.46% from the prior year.
• Short-term Investments for Q2 2026 stood at $2.2 million, up from $1.1 million in the prior quarter.
• The five-year high for Short-term Investments was $2.2 million in Q2 2026, with the low at $1084.0 in Q3 2025.
• The 5-year median for Short-term Investments is $86112.0 (2023), against an average of $389177.9.
• The sharpest annual moves came in 2024 and 2026: Short-term Investments plunged 91.59% in 2024, then jumped 1125.77% in 2026.
• Clearmind Medicine's Short-term Investments stood at $15057.9 in 2022, then surged by 471.87% to $86112.0 in 2023, then jumped by 236.06% to $289388.0 in 2024, then jumped by 474.46% to $1.7 million in 2025, then soared by 30.98% to $2.2 million in 2026.
• Business Quant data shows CMND's Short-term Investments at $2.2 million in Q2 2026, $1.1 million in Q1 2026, and $1.7 million in Q4 2025.